SLC12A5 and Huntington disease: Indeed, with the broad functions (independent of ion transport) of KCC2, it’s no surprise that reduced GABAergic inhibition is not the only phenotype in KCC2-related pathologies and may contribute to other symptoms in HD (Tang, 2020; Virtanen et al., 2021).